Geriatric Healthcare Specialist Jonesboro AR

In a study recently published in the Journal of Alzheimer’s Disease, researchers from Brown Medical School found that reduced glucose uptake and decreased metabolism in the hippocampus—the area of the brain associated with memory—cause neurodegeneration and cognitive impairment.

Terry Dean Weaver, MD
(808) 523-8461
528 E Washington Ave
Jonesboro, AR
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Male
Education
Medical School: In Univ Sch Of Med, Indianapolis In 46202
Graduation Year: 1995

Data Provided by:
Thomas Mulligan
(870) 336-5080
303 E Matthews Ave Ste 202
Jonesboro, AR
Specialty
Internal Medicine, Geriatric Medicine

Data Provided by:
Nana Kwadwo Britwum, MD
(312) 633-6519
228 W Tyler Ave
West Memphis, AR
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Male
Education
Medical School: Univ Of Ghana, Med Sch, Accra, Ghana
Graduation Year: 1997

Data Provided by:
Cynthia Jean Brown, MD
(479) 442-2020
594 E Millsap Rd
Fayetteville, AR
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Female
Education
Medical School: Univ Of Nc At Chapel Hill Sch Of Med, Chapel Hill Nc 27599
Graduation Year: 1996

Data Provided by:
Henry Nathaniel Edwards, MD
(501) 474-5001
822 Broadway St
Van Buren, AR
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Male
Education
Medical School: Univ Of Ks Sch Of Med, Kansas City Ks 66103
Graduation Year: 1976
Hospital
Hospital: Sparks Reg Med Ctr, Fort Smith, Ar; Crawford Memorial Hosp, Van Buren, Ar
Group Practice: Sophia Meyer Medical Plc

Data Provided by:
James Mark Robinette
(870) 932-2423
801 Osler Dr Ste A
Jonesboro, AR
Specialty
Family Practice, Geriatric Medicine

Data Provided by:
Evgueni Roudachevski
(501) 227-8020
11912 Kanis Road
Little Rock, AR
Specialty
Internal Medicine, Geriatric Medicine

Data Provided by:
Michele Soraya Shrikanthan
(479) 750-6566
2423 North Thompson
Springdale, AR
Specialty
Geriatric Medicine

Data Provided by:
Owen W Beard, MD, FACC
7008 Rockwood Rd
Little Rock, AR
Specialties
Cardiology, Geriatrics
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Vinay Vengareddigari Kutagula, MD
(501) 223-8805
4301 W Markham St
Little Rock, AR
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Male
Education
Medical School: Osmania Med Coll, Univ Hlth Sci, Vijayawada, Hyderabad, Ap, India
Graduation Year: 1997

Data Provided by:
Data Provided by:

Food for Thought

Provided by: 

By Kris Kucera

Rarely does an extended family get a free pass from Alzheimer’s disease or diabetes mellitus. On the surface, these two afflictions appear totally unrelated —Alzheimer’s (AD), Mother Nature’s cruel version of identity theft; and diabetes, the glucose-metabolism disorder that affects both young and old alike. However, new research indicates that the two diseases behave in a similar manner.

In a study recently published in the Journal of Alzheimer’s Disease, researchers from Brown Medical School found that reduced glucose uptake and decreased metabolism in the hippocampus—the area of the brain associated with memory—cause neurodegeneration and cognitive impairment. This, they say, suggests that a form of diabetes, tentatively dubbed type 3, leads to AD.

Type 1 diabetes results from a severe or complete lack of insulin, a hormone made in the pancreas that controls blood sugar. Type 2, dubbed adult onset diabetes (although these days it occurs in teenagers and even younger kids), also stems from a dearth of insulin, or insulin resistance —the existing insulin molecules cannot deliver glucose through the cells’ membranes. Surprisingly, the researchers found a new form of insulin, produced in the brain, and they believe that, over time, decreasing levels of this “brain insulin” and other insulin-related proteins ultimately precipitate AD. While levels of brain insulin have no known affect on a body’s overall blood sugar, scientists have long recognized that diabetes patients are more likely to develop AD than those without the disease.

Skeptics of the Brown team’s findings argue that our brains produce so little insulin in the first place, reduced levels of the hormone can’t possibly play a significant role in AD. Regardless, the new data show that AD may be a neuroendocrine disorder, thus increasing the possibility for more effective treatments. And that gives hope to all of us who may one day be touched, directly or indirectly, by the merciless hand of AD.

Copyright 1999-2009 Natural Solutions: Vibrant Health, Balanced Living/Alternative Medicine/InnoVisi...